Areteia Announces Appointment of Daniel Becker To Board of Directors
15 Feb 2024 //
BUSINESSWIRE
Areteia Therapeutics Announces Additional $75MM in Series A Financing
13 Feb 2024 //
BUSINESSWIRE
Areteia to Present at the 42nd Annual J.P. Morgan Healthcare Conference
03 Jan 2024 //
BUSINESSWIRE
Areteia Therapeutics Announces Publication of PII Data of Oral Dexpramipexole
03 Aug 2023 //
BUSINESSWIRE
Areteia Therapeutics Announces Appointment of Elyse Stock, M.D. ToBOD
20 Apr 2023 //
BUSINESSWIRE
Areteia begins subject dosing in eosinophilic asthma therapy trials
10 Mar 2023 //
CLINICAL TRIALS ARENA
Areteia Announces Start of Phase III Trials of Oral Dexpramipexole
09 Mar 2023 //
BUSINESSWIRE